PharMerica Corporation (PMC)
-NYSE 14.67 
0.57(4.04%) May 24, 4:01PM EDT
| Prev Close: | 14.10 |
|---|
| Open: | 13.97 |
|---|
| Bid: | 11.80 x 100 |
|---|
| Ask: | 17.46 x 100 |
|---|
| 1y Target Est: | 16.83 |
|---|
| Beta: | 1.13 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 13.93 - 14.86 |
|---|
| 52wk Range: | 9.03 - 15.42 |
|---|
| Volume: | 689,875 |
|---|
| Avg Vol (3m): | 243,562 |
|---|
| Market Cap: | 435.63M |
|---|
| P/E (ttm): | 15.77 |
|---|
| EPS (ttm): | 0.93 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 5 Stocks Soaring on Unusual Volumeat TheStreet(Fri, May 24)
- July Options Now Available For PharMerica (PMC)at TheStreet(Mon, May 20)
- Industry Tailwinds Give PharMerica A Long Runway For Growthat Seeking Alpha(Wed, May 15)
- PharMerica to Present at the Bank of America Merrill Lynch 2013 Health Care ConferenceBusiness Wire(Tue, May 14)
- McKesson Earnings Down in 4QZacks(Wed, May 8)
- PHARMERICA CORP FinancialsEDGAR Online Financials(Tue, May 7)
- Pharmerica Corporation Stock Upgraded (PMC)at TheStreet(Tue, May 7)
- 3 Healthcare Stock Winners and 1 Loser Post Earningsat Wall St. Cheat Sheet(Sat, May 4)
- PharMerica Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 2)
- Why PharMerica Shares Poppedat Motley Fool(Thu, May 2)
- PHARMERICA CORP Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Thu, May 2)
- PharMerica Corporation Earnings Call scheduled for 10:00 am ET todayCCBN(Thu, May 2)
- PharMerica Earnings: Everything You Must Know Nowat Wall St. Cheat Sheet(Wed, May 1)
- PharMerica Reports Results for the First Quarter of 2013Business Wire(Wed, May 1)
- Looking Into The Specialty Pharmacy Sectorat Seeking Alpha(Wed, May 1)
Key Statistics
| Forward P/E (1 yr): | 9.53 |
|---|
| P/S (ttm): | 0.24 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.48 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.34 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 1.11 |
|---|
Business Summary
PharMerica Corporation operates as an institutional pharmacy services company in the United States. It offers services to healthcare facilities; management pharmacy services to hospitals; and specialty infusion services to patients outside hospitals.
View More